Abstract:Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are complex, multifactorial disorders that lead to chronic and relapsing intestinal inflammation. The exact etiology remains unknown, however multiple factors including the environment, genetic, dietary, mucosal immunity, and altered microbiome structure and function play important roles in disease onset and progression. Supporting this notion that the gut microbiota plays a pivotal role in IBD pathogenesis, studies in gnotobiotic mice have shown that mouse models of intestinal inflammation require a microbial community to develop colitis. Additionally, antimicrobial therapy in some IBD patients will temporarily induce remission further demonstrating an association between gut microbes and intestinal inflammation. Finally, a dysfunctional intestinal epithelial barrier is also recognized as a key pathogenic factor in IBD. The intestinal epithelium serves as a barrier between the luminal environment and the mucosal immune system and guards against harmful molecules and microorganisms while being permeable to essential nutrients and solutes. Beneficial (i.e., mutualists) bacteria promote mucosal health by strengthening barrier integrity, increasing local defenses (mucin and IgA production) and inhibiting pro-inflammatory immune responses and apoptosis to promote mucosal homeostasis. In contrast, pathogenic bacteria and pathobionts suppress expression and localization of tight junction proteins, cause dysregulation of apoptosis/proliferation and increase pro-inflammatory signaling that directly damages the intestinal mucosa. This review article will focus on the role of intestinal epithelial cells (IECs) and the luminal environment acting as mediators of barrier function in IBD. We will also share some of our translational observations of interactions between IECs, immune cells, and environmental factors contributing to maintenance of mucosal homeostasis, as it relates to GI inflammation and IBD in different animal models.

Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease

Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease

Sentinels at the frontline: the role of intraepithelial lymphocytes in inflammatory bowel disease

Innate Lymphoid Cells as Regulators of Epithelial Integrity: Therapeutic Implications for Inflammatory Bowel Diseases

Immune cell-derived signals governing epithelial phenotypes in homeostasis and inflammation

Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease

TH17 Cell and Epithelial Cell Crosstalk during Inflammatory Bowel Disease and Carcinogenesis

Intestinal barrier function: Molecular regulation and disease pathogenesis

Policing the Intestinal Epithelial Barrier: Innate Immune Functions of Intraepithelial Lymphocytes

Epithelial Barriers in Intestinal Inflammation

Epithelial Cell Shedding and Barrier Function

Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease

[Functional relevance of intestinal epithelial cells in inflammatory bowel disease]

Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier

Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease—Focusing on Intestinal Barrier Function

The intestinal immunoendocrine axis: novel cross-talk between enteroendocrine cells and the immune system during infection and inflammatory disease

Wall of Resilience: How the Intestinal Epithelium Prevents Inflammatory Onslaught in the Gut

Intestinal mucosal barrier function in health and disease

The Regulation of Intestinal Inflammation and Cancer Development by Type 2 Immune Responses

Intestinal barrier: Molecular pathways and modifiers

Intestinal epithelial cells: regulators of barrier function and immune homeostasis